DOCSLIB.ORG

Proceedings of the 18Th AFES Congress 2015

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Proceedings of the 18Th AFES Congress 2015 JAFES Journal of the ASEAN Federation of Endocrine Societies Volume 30 Number 2 ISSN 0857-1074 November 2015 Proceedings of the 18th AFES Congress 2015 The Biennial Scientific Meeting of the ASEAN Federation of Endocrine Societies The statements and opinions expressed in this publication are those of the individual authors and do not necessarily reflect the views of the Malaysian Endocrine and Metabolic Society (MEMS). MEMS, together with all its agents and suppliers, are not responsible or liable in any way for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising therefrom. With respect to any drugs mentioned, the reader is advised to refer to the appropriate medical literature and the product information currently provided by the manufacturer to verify appropriate dosage, method and duration of administration, and other relevant information. In all instances, it is the responsibility of the treating physician or other healthcare professional, relying on independent experience and expertise, as well as knowledge of the patient, to determine the best treatment for the patient. Copyright © December 2015 by the Malaysian Endocrine and Metabolic Society (MEMS). All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted in any form, by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission of the publisher. 003 | CONTENTS AFES INVESTIGATOR AWARD (AIA) ABSTRACT LISTING AFES INVESTIGATOR AWARD (AIA) ABSTRACTS 041 AIA 1 Evaluation of Beta Cell Dysfunction by Mixed-Meal Tolerance Test Among Vietnamese with Newly Diagnosed Type 2 Diabetes Van Phan Thi Tuong, Khanh Tran Quang University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam 042 AIA 2 Modifying Effect of Body Mass Index on Survival in Elderly Type 2 Diabetic Patients - Hong Kong Diabetes Registry Kitty Cheung, Jiang Guozhi, Jenny Lee, Andrea Luk, Alice Kong, Risa Ozaki, Ronald Ma, Francis Chow, Juliana Chan, So Wing Yee Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR 043 AIA 3 Genetics of Diabetes: The Variant of Transcription Factor 7-Like 2 (TCF7L2) Gene and the Prediction of Diabetes Risk in Diabetic Families Dr Abbasali Palizban Department of Clinical Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Iran. 044 AIA 4 MODY 2 Diabetes: 3 Years of Follow Alla Ovsyannikova, Oksana Rymar, Vladimir Maximov, Elena Voropaeva, Mikhail Voevoda Federal State Budgetary Scientific Institution “Scientific Research Institute of Therapy and Preventive Medicine” 045 AIA 5 The Development of a Risk Score in Predicting Hypoglycaemia Admissions for Patients with Type 2 Diabetes Mellitus Kurumbian Chandran, Yu Weichang, Christine Wu, Darren Seah Ee-Jin, Matthias Paul Toh Han Sim Ng Teng Fang General Hospital, Singapore; National Healthcare Group, Singapore; National Healthcare Group Polyclinics, Singapore 046 AIA 6 Free 25-Hydroxyvitamin D Levels, Polymorphism of Viatmin D Binding Protein Gene and Risk for Gestational Diabetes Mellitus Natthinee Charatcharoenwitthaya1, Charintip Somprasit2, Athita Chanthasenanont2, Laor Chailurkit3, Suwannee Chanprasertyothin3, Boonsong Ongphiphadhanakul3 1Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Thammasat University, Thailand; 2Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Thailand; 3Endocrinology and Metabolism, Department of Medicine, Ramathibodi Hospital, Mahidol University, Thailand 004 | CONTENTS AFES INVESTIGATOR AWARD (AIA) ABSTRACT LISTING 047 AIA 7 Predictors of Secondary Intervention in Surgically Resected Non-Functioning Pituitary Adenoma Jeyakantha Ratnasingam1,2, Benjamin Ong3,4, Anthony Russell2,4, Warrick Inder2,4, Ken KY Ho2,4 1Endocrine Unit, Department of Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia, 2Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Queensland, Australia, 3Department of Diagnostic Radiology, Princess Alexandra Hospital, Brisbane, Queensland, Australia, 4School of Medicine, University of Queensland, Australia 048 AIA 8 CYP11B2, CYP17A1 and KCNJ5 Protein Expression in Aldosterone-producing Adenomas (APA) with or without CACNA1D Somatic Mutations Elena Azizan, Norlela Sukor, Nor Azmi Kamaruddin, Isa Mohamed Rose, Tan Geok Chin The National University of Malaysia (UKM) Medical Centre 049 AIA 9 Long Sleep Duration is Associated with Insulin Resistance Independently of Obesity in Korean Non-Diabetic Adults Ki Dong Ko, Kyoung Kon Kim, Heuy Sun Suh, In Cheol Hwang Department of Family Medicine, Gachon University Gil Medical Center, Republic of Korea 050 AIA 10 Dietary penta-O-galloyl-α-D-glucose (PGG) Reduces Blood Glucose and Triglyceride in Obese Mice and Expression of PPARγ, C/EBPα, and Induces p21-mediated G1 Phase Cell Cycle Arrest and Inhibits Adipogenesis in 3T3-L1 Preadipocytes Ahmed Malki1, Xueqing Liu2,3, Yanyan Cao2,4,5, Yunsheng Li2, Yanrong Qian2,3,5, Xuan Wang2,4,5, Xiaozhuo Chen2-6, Asmaa Althani7 1Department of Health Sciences, Biomedical Sciences Program, Faculty of Science, College of Arts and Sciences, Qatar University, Doha, Qatar, 2Edison Biotechnology Institute, 3Department of Chemistry and Biochemistry 4Department of Biologic Science, 5Molecular and Cellular Biology Program and 6Department of Biomedical Sciences, Ohio University, Athens Ohio 45701, 7Biomedical Research Center, Qatar University, 2713 Doha, Qatar. 051 AIA 11 Thyroid Stimulating Hormone Receptor Gene Intron 1 and Regulatory T Cells are Risk Factor of Relapse in Graves Disease Fatimah Eliana1, Pradana Suwondo2, Asmarinah2, Alida Roswita Harahap2, Joedo Prihartono2, Tjokorda Gde Dalem Pemayun3 1YARSI University, 2University of Indonesia, 3Diponegoro University 005 | CONTENTS ORAL (O) ABSTRACT LISTING ORAL (O) ABSTRACTS 052 O1 Prospective Study Suggests that Central Arterial Stiffness Independently Predicts Albuminuria Progression in Asians with Type 2 Diabetes Lim Su Chi, Zhang Xiao, Li Na, Liu Jian Jun, Angela MC Moh, Su Chang, Serena KM Low, Tavintharan Subramaniam, Yeoh Lee Ying, Sum Chee Fang Diabetes Centre, Clinical Research Unit & Department of Medicine, Khoo Teck Puat Hospital, Singapore 053 O2 Single Nucleotide Polymorphism at +45 T>G of the Adiponectin Gene and Plasma Adiponectin Level in Type 2 Diabetes Mellitus Khin Thin Yu, Kyu Kyu Maung, Theingi Myint, Khin Win Sein, Ko Ko, Thein Myint Myanmar Society of Endocrinology and Metabolism (MSEM) 054 O3 Incidence of Decreased Glomerular Filtration Rate and Associated Risk Factors in Patients with Type 2 Diabetes Phat Ma Tung, Khue Nguyen Thy University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam 055 O4 Microvascular & Macrovascular Complications in Young Onset Type 2 Diabetes in a Tertiary Health Institution in Malaysia in Comparison with Type 1 Diabetes Patients (MiMaCom) Lim Kim Piow, Foo Siew Hui, Liew Kean Yew, Kavitha Arumugam, Nurafna Mohd Jaafar, Choo Yung Zhuang, Wong Yen Shen Endocrine Unit, Department of Medicine, Selayang Hospital, Selangor, Malaysia 056 O5 Association of Metabolic Syndrome with Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Kuhu Roy, Uma Iyer, Rumin Shah, Tushar Vaishnav Department of Foods and Nutrition, Faculty of Family and Community Sciences, The Maharaja Sayajirao University of Baroda, Vadodara-390007, Gujarat, India. 057 O6 Use of Continuous Glucose Monitoring in Patients with Diabetic Kidney Disease with Suboptimal Glycemic Control Ester Yeoh, Sharon Fun, Julia Tong, Lim Boon Khim, Tavintharan S., Sum Chee Fang, Yeoh Lee Ying, Lim Su Chi Khoo Teck Puat Hospital, 90 Yishun Central, Singapore 768828 058 O7 Prognostic Factors in Patients Hospitalised with Diabetic Ketoacidosis Manish Gutch, Sukriti Kumar, Syed Mohd Razi, Abhinav Gupta, Keshav Kumar Gupta Department of Endocrinology, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, India; Department of Radio diagnosis, SGPGI, Lucknow, Uttar Pradesh, India 006 | CONTENTS ORAL (O) ABSTRACT LISTING 059 O8 Glycemic Variability Among Older Adults with Type 2 Diabetes Tong Chin Voon, Nurain Mohd Noor, Masni Mohamad, Zanariah Hussein Endocrine Unit, Department of Medicine, Hospital Putrajaya, Malaysia 060 O9 Glycemic Indices of Traditional Javanese Foods in the Healthy State and Type 2 Diabetes Teky Widyarini, Supriyanto Kartodarsono, Sugiarto, Eva Niamuzisilawati Endocrinology Division, Internal Medicine Department, Faculty of Medicine Sebelas Maret University- Dr. Moewardi Hospital Surakarta 061 O10 Effect of Cosmos Caudatus (Ulam Raja) on Glycemic and Cardiovascular Risk Factors in Type 2 Diabetic Patients: A Randomized Controlled Trial Cheng Shi-Hui, Amin Ismail, Joseph Anthony, Ng Ooi Chuan, Azizah Abdul Hamid, Barakatun Nisak Mohd Yusof Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia; Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia; Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Selangor, Malaysia. 062 O11 Correlation of Phospholipase (sPLA2 IIA) Enzime’s Level and Severity of Diabetic Renal Disease in Type 2 Diabetic Patients Harli Amir Mahmudji1, R. Bowo Pramono2, Hemi Sinorita2, M. Robikhul Ikhsan2 1Internal Medicine – Prof. dr. Soeroyo Mental Health Hospital, Magelang;
Load more

Recommended publications
  • Chapter 1. Epidemiology of Hypertension
    Hypertension Research (2009) 32, 6–10 & 2009 The Japanese Society of Hypertension All rights reserved 0916-9636/09 $32.00 www.nature.com/hr GUIDELINES (JSH 2009) Chapter 1. Epidemiology of hypertension Hypertension Research (2009) 32, 6–10; doi:10.1038/hr.2008.9 POINT 1 Similar values were also reported in the quick report of the National Health and Nutrition Survey in 2006. The number of hypertensive 1. The number of hypertensive people in Japan has reached Japanese is expected to increase further with the growth in the elderly approx 40 million. population. 2. The average blood pressure levels of the Japanese decreased markedly following a peak in 1965–1990. This decrease 2) CHANGES IN AVERAGE BLOOD PRESSURE LEVELS OF THE closely coincided with the decrease in mortality rate due to JAPANESE stroke in Japan. In Japan, with the successful management of infections following 3. Morbidity and mortality rates due to diseases such as stroke, World War II, the age-adjusted mortality rate due to stroke increased myocardial infarction, heart disease and chronic renal dis- rapidly and reached a peak in 1965. It then decreased rapidly until ease increase with elevating blood pressure. The effects of 1990, and the life expectancy of the Japanese became the longest in the hypertension are more specific to stroke than to myocardial world.1 During this period, the morbidity rate from stroke decreased, infarction, and, in Japan, the morbidity rate due to stroke is contributing greatly to the reduction in mortality rate due to stroke, still higher than that due to myocardial infarction.
    [Show full text]
  • Chapter 13. Secondary Hypertension
    Hypertension Research (2014) 37, 349–361 & 2014 The Japanese Society of Hypertension All rights reserved 0916-9636/14 www.nature.com/hr GUIDELINES (JSH 2014) Chapter 13. Secondary hypertension Hypertension Research (2014) 37, 349–361; doi:10.1038/hr.2014.16 OVERVIEW AND SCREENING approximately 5–10% of hypertensive patients,984,985 and it is the most Hypertension related to a specific etiology is termed secondary frequent in endocrine hypertension. In addition, frequent etiological hypertension, markedly differing from essential hypertension, of factors for secondary hypertension include renal parenchymal hyper- which the etiology cannot be identified, in the condition and tension and renovascular hypertension. A study reported that sleep therapeutic strategies. Secondary hypertension is often resistant hyper- apnea syndrome was the most frequent factor for secondary hyper- tension, for which a target blood pressure is difficult to achieve by tension.517 The number of patients with secondary hypertension standard treatment. However, blood pressure can be effectively may further increase with the widespread diagnosis of sleep apnea reduced by identifying its etiology and treating the condition. There- syndrome. fore, it is important to suspect secondary hypertension and reach an Generally, the presence of severe or resistant hypertension, juvenile appropriate diagnosis. hypertension and the rapid onset of hypertension suggest the possi- Frequent etiological factors for secondary hypertension include bility of secondary hypertension. In such hypertensive patients, a close renal parenchymal hypertension, primary aldosteronism (PA), reno- inquiry on medical history, medical examination and adequate vascular hypertension and sleep apnea syndrome. Renal parenchymal examinations must be performed, considering the possibility of hypertension is caused by glomerular diseases, such as chronic secondary hypertension.
    [Show full text]
  • California Breast Cancer Research Program Special Research Initiatives
    Identifying Gaps in Breast Cancer Research California Breast Cancer Research Program Special Research Initiatives Identifying gaps in breast cancer research: Addressing disparities and the roles of the physical and social environment Editors Julia G. Brody, PhD Executive Director Silent Spring Institute Marion (Mhel) H.E. Kavanaugh-Lynch, MD, MPH Director California Breast Cancer Research Program Olufunmilayo I (Funmi) Olopade, MD Walter L. Palmer Distinguished Service Professor of Medicine University of Chicago Medical Center Susan Matsuko Shinagawa Breast Cancer and Chronic Pain Survivor/Advocate, Intercultural Cancer Council; Asian and Pacific Islander National Cancer Survivors Network Sandra Steingraber, PhD Author and Distinguished Visiting Scholar Ithaca College David R. Williams, PhD Department of Society, Human Development and Health Harvard School of Public Health Front Matter DRAFT 8/11/07 Page 1 California Breast Cancer Research Program Table of Contents Preface Introduction Section I: Exposures from the Physical Environment and Breast Cancer Overarching Issues A. Secondhand Smoke B. Environmental Chemicals/Pollutants 1. Air Pollutants, Fuels and Additives 2. Persistent Organic Pollutants 3. Polybrominated Flame Retardants 4. Pesticides 5. Solvents and industrial chemicals 6. Water Contaminants 7. Hormones in Food 8. Metals 9. Exposures from Polyvinyl Chloride 10.Bisphenol A C. Compounds in Personal Care Products D. Pharmaceuticals E. Infectious agents F. Ionizing Radiation G. Electric and Magnetic Fields H. Light at night I. Vitamin D/Sunlight Section II: Disparities in Breast Cancer: Domains of Individual-level Social Inequality A. Race/Ethnicity B. Sexual Minority Women C. Disability Status D. Culture E. Health Insurance Section III: Neighborhood Context and Breast Cancer Front Matter DRAFT 8/11/07 Page 2 Identifying Gaps in Breast Cancer Research Acknowledgements The California Breast Cancer Research Program would like to acknowledge the assistance from the following individuals who participated in the development of these chapters.
    [Show full text]
  • Endocrine Abstracts Vol 44
    Endocrine Abstracts November 2016 Volume 44 ISSN 1479-6848 (online) Society for Endocrinology BES 2016 7–9 November 2016, Brighton, UK published by Online version available at bioscientifica www.endocrine-abstracts.org Volume 44 Endocrine Abstracts November 2016 Society for Endocrinology BES 2016 7–9 November, The Brighton Centre Brighton, UK EDITORS The abstracts submitted were marked by the Abstract Marking panel selected by the Programme Committee Programme Committee S Pearce (Chair of the Programme Committee) G Lavery (Programme Co-ordinator) R Semple (Programme Co-ordinator) Members R Andrew N Gittoes S Miczuk E Crowne K Hardy S Pearce E Davies P King L Shepherd M Druce A Logan A Toogood W Farrell C McCardle Co-opted members H Christian V Smith (Birmingham) H Simpson Abstract Marking Panel James Ahlquist Julian Davis Brian Keevil Salman Razvi Ramzi Ajjan Colin Dayan Nikki Kieffer Martin Read Ruth Andrew Miguel DeBono Marta Korbonits Aled Rees Rob Andrews Waljit Dhillo Nils Krone Philippa Saunders Weibke Arlt Will Drake Gareth Lavery Peter Selby Mo Aye Colin Duncan Graham Leese Lisa Shepherd Simon Aylwin William Farrell Jacques Lenders Helen Simpson John Ayuk Rob Fowkes Andy Levy Vicki Smith Tom Barber Jayne Franklyn Miles Levy Roland Stimson Julian Barth Bill Fraser Stafford Lightman Abd Tahrani Andy Bates William Fraser Craig A McArdle Tricia Tan Kristien Boelaert Marie Freel Phil McTernan Christina Thirlwell Pierre Bouloux Neil Gittoes Daniel Morganstein Tony Toft Paul Carroll Helena Gleeson Damian Morris Jeremy Tomlinson Karen Chapman Mark Gurnell Kevin Murphy Mark Vanderpump Krishna Chatterjee Fadil Hannan Rob Murray Gwen Wark Tim Cheetham Pippa Hanson John Newell-Price Tony Weetman Juliet Compston Steve Hillier Simon Pearce Melissa Westwood Sue Cox Megan Holmes Colin Perry Anna Crown Andy James Pat Pickett Eleanor Davies Niki Karavitaki Richard Quinton Society for Endocrinology BES 2016 Corporate supporters The Society for Endocrinology would like to thank its Corporate Supporters for their generous financial assistance.
    [Show full text]
  • Surgical Treatment of Hypertension Wessel Vorselaars
    SURGICAL TREATMENT OF HYPERTENSION OF HYPERTENSION SURGICAL TREATMENT SURGICAL TREATMENT OF HYPERTENSION Preoperative work-up and surgical treatment of primary aldosteronism in current daily practice WESSEL VORSELAARS WESSEL VORSELAARS SURGICAL TREATMENT OF HYPERTENSION Preoperative work-up and surgical treatment of primary aldosteronism in current daily practice WESSEL VORSELAARS Surgical treatment of hypertension Preoperative work-up and surgical treatment of primary aldosteronism in current daily practice PhD thesis, Utrecht University, the Netherlands © Wessel Mathieu Corneel Marie Vorselaars, 2019 ISBN 978-94-6380-445-5 Layout and design wenz iD || Wendy Schoneveld Printed by ProefschriftMaken || www.proefschriftmaken.nl All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any means without prior written permission from the author. The copyright of the papers that have been published or have been accepted for publication, has been transferred to the concerning journal. Financial support by the Dutch Heart Foundation for the publication of this thesis is gratefully acknowledged. Other sponsors: ChipSoft and RG Wedding Photography (www.rgphotography.nl) SURGICAL TREATMENT OF HYPERTENSION Preoperative work-up and surgical treatment of primary aldosteronism in current daily practice DE CHIRURGISCHE BEHANDELING VAN HYPERTENSIE De preoperatieve work-up en de chirurgische behandeling van primair hyperaldosteronisme in de hedendaagse praktijk Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof. dr. H.R.B.M. Kummeling, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op donderdag 19 september 2019 des middags te 12.45 uur door Wessel Mathieu Corneel Marie Vorselaars geboren op 24 mei 1990 te Utrecht Promotoren: Prof.
    [Show full text]
  • 16Th July 2001
    AUSTRALASIAN ASSOCIATION OF CLINICAL BIOCHEMISTS INC 5/85 Bourke Rd, Alexandria NSW, 2015 Telephone: +61 2 9669 6600 Facsimile: +61 2 9669 6607 Email: [email protected] Draft Guideline Title Harmonisation of Endocrine Dynamic Testing (HEDT) Document Number: 2018 DGD02 Publication date: Draft for comment September 2018 Next review date: Owner: ESA/AACB/RCPA HEDT Working Party This draft manual for Harmonisation of Endocrine Dynamic Testing is a joint initiative from ESA/AACB/RCPA and is now open for comment and feedback for 90 days. Information provided is a guide only and needs to be verified and modified according to local procedures (e.g. patient consent, sample type, name of test set). A separate paediatric endocrine dynamic testing protocol is in progress with the HDET-P working party. Please direct comments to the chair of the HEDT working party: Dr Cherie Chiang ([email protected]) with the subject heading " HEDT feedback" 2018 DGD02 Harmonisation of Endocrine Dynamic Testing (HEDT) This manual is a joint initiative from ESA/AACB/RCPA and is freely available as a resource for Endocrinologists and Biochemists. Information provided is a guide only and needs to be verified and modified according to local procedures (e.g. patient consent, sample type, name of test set). Queries can be directed to the chair of the HEDT working party. A separate paediatric endocrine dynamic testing protocol is in progress with the HDET-P working party. 2018 DGD02 Page 1 Table of Contents HEDT Working Group Members: ...........................................................................................................4
    [Show full text]
  • Primary Hyperaldosteronism: Screening, Diagnosis, and Management for the Clinician Eugene T
    Archives of Diabetes and Endocrine System ISSN 2638-4981 Volume 1, Issue 2, 2018, PP:39-48 Primary Hyperaldosteronism: Screening, Diagnosis, and Management for the Clinician Eugene T. Van, DO1, Winnie Nhan, DO2*, Kristyn Perry, DO3, Azadeh Brumand, DO4 Serena Shen, DO5, Kelvin L. Tran, DO6, Quang T. Nguyen, DO, FACP, FACE, FTOS7 1, 2, 3, 4, 6 5 Department of Internal Medicine, Valley Hospital Medical Center, Las Vegas, NV. 7 Department of Family Medicine, Valley Hospital Medical Center, Las Vegas, NV. Medical Director, Las Vegas Endocrinology, Clinical Associate Professor, Clinical Education, AZCOM, and *Corresponding Author: Winnie Nhan, DO, Department of Internal Medicine, Valley Hospital Medical Center, Las Adjunct Associate Professor of Endocrinology, Touro University Nevada. Vegas, NV, USA. Abstract Primary hyperaldosteronism (PA) is the most common secondary, non-iatrogenic cause of hypertension. This condition is associated with significant risk of morbidity and mortality, yet it is often unrecognized and undiagnosed in the primary care setting. Screening with the aldosterone to renin ratio (ARR) should be considered in patients with resistant hypertension, defined as blood pressure >140/90 mmHg despite the use of three different classes of antihypertensive medications, including a diuretic. The goal of this review is to inform the primary care clinician of the current guideline recommendations for screening, confirming, subtyping, and treating primary hyperaldosteronism. Introduction hypertension is frequently recognized and treated Hypertension affects up to 75 million adults in America, in the primary care setting, secondary hypertension with an estimated cost of $46 billion in annual health is often overlooked and remains untreated. The care utilization, prescription medications, and missed most common cause of secondary hypertension work days (11).
    [Show full text]
  • Syndrome. See VIP-Oma of the Pancreas ACTH. See Adrenocorticot
    Index A occult tumors in, 52-53 Abdomen, computed tomography of, 29f, 30f, 51 Adrenogenital syndrome, 38 Achlorhydria (WDHR) syndrome. See VIP-oma of Aldosterone, effects of, 36 the pancreas Aldosterone and primary aldosteronism (Conn's ACTH. See Adrenocorticotropic hormone syndrome),155-159 Addison's disease, 31, 133 aldosterone suppression tests, 157-158 Adrenal carcinoma, arteriography of, 43f determination of plasma aldosterone precursors, Adrenal cortex 158 aldosterone-producing tumors of, 36 determination of plasma and urinary aldosterone diseases of, 33-38 levels, 156 Adrenal cortical carcinomas, 42-43 determination of plasma renin activity or Adrenal glands, 28-32 concentration, 155-156 adrenal scintigraphy in, 28 determination of plasma/serum electrolytes, 155 close interaction between gonads and, 21 individual basal levels, 158f computed tomography of, 28-30, 32 postural stimulation test, 156-157 in Cushing's disease, 35f response to spironolactone trial, 159 in macro nodular hyperplasia, 35 twenty-four-hour urinary aldosterone excretion magnetic resonance imaging (MRI) in, 30-32 rates, 158f malignant tumors of, 42-43 Aldosteronism, treatment of, 38 single adenoma of, 50f Aldosteronoma, in Conn's syndrome, 37f ultrasonography in, 28, 32 Amine-precursor uptake and decarboxylation venous sampling in, 32 (APUD),75 Adrenal hemorrhage, 31 Androgen-producing adrenal neoplasias, 162-163 Adrenal hormone excess, 36-38 Androgen-producing tumors, 38 Adrenal hyperplasia, 34f Androgen-secreting ovarian tumors, 25t Adrenal imaging, indications
    [Show full text]
  • Role of Endogenous ACTH on Circadian Aldosterone Rhythm in Patients with Primary Aldosteronism
    T Sonoyama et al. ACTH on aldosterone secretion 1–7 3:173 Research in aldosteronism Open Access Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism Takuhiro Sonoyama, Masakatsu Sone, Naohisa Tamura, Kyoko Honda, Correspondence Daisuke Taura, Katsutoshi Kojima, Yorihide Fukuda, Naotetsu Kanamoto, should be addressed Masako Miura, Akihiro Yasoda, Hiroshi Arai, Hiroshi Itoh and Kazuwa Nakao to M Sone Email Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, sonemasa@kuhp. 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan kyoto-u.ac.jp Abstract We recently reported that stimulation with high-dose ACTH caused different responses in Key Words terms of aldosterone secretion in aldosterone-producing adenomas (APAs) and idiopathic " primary hyperaldosteronism hyperaldosteronism (IHA) in patients with primary aldosteronism (PA). However, the role of " hypertension endogenous ACTH in aldosterone secretion in PA has not been systematically evaluated. " adrenal gland In this study, we examined diurnal changes in plasma aldosterone concentration (PAC), and " adrenocorticotropic hormone changes in PAC after dexamethasone administration in patients with suspected PA, in order " clinical medicine to evaluate the effect of endogenous ACTH on aldosterone secretion. Seventy-three patients Endocrine Connections admitted to Kyoto University Hospital with suspected PA were included. The patients were classified into non-PA, IHA, and APA groups according to the results of captopril challenge test and adrenal venous sampling. PAC at 0900 h (PAC0900), 2300 h (PAC2300), and after 1-mg dexamethasone suppression test (PACdex) was measured and compared among the three groups. The PAC2300/PAC0900 and PACdex/PAC0900 ratios were also analyzed.
    [Show full text]
  • Clinical and Investigative Endocrinology and Diabetes
    APRIL 2017 VOLUME 23 SUPPLEMENT 3 Clinical and Investigative Endocrinology and Diabetes 2017 AACE ANNUAL SCIENTIFIC & CLINICAL CONGRESS ABSTRACTS ABSTRACT CATEGORIES 1 Adrenal Disorders 121 Obesity 29 Diabetes Mellitus/Prediabetes 131 Other 83 Hypoglycemia 161 Pituitary Disorders/Neuroendocrinology 95 Lipid/Cardiovascular Disorders/Hypertension 227 Reproductive Endocrinology 99 Metabolic Bone Disease 247 Thyroid Disease OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN COLLEGE OF ENDOCRINOLOGY • WWW.AACE.COM ABSTRACTS Table of Contents Adrenal Disorders . 1 Diabetes Mellitus/Prediabetes . 29 Hypoglycemia . 83 Lipid/Cardiovascular Disorders/Hypertension . 95 Metabolic Bone Disease . 99 Obesity . 121 Other . 131 Pituitary Disorders/Neuroendocrinology . .161 Reproductive Endocrinology . 191 Thyroid Disease . 209 Author Index . 263 Notes . 277 ABSTRACTS ADRENAL DISORDERS the presence of gonads. Primary or ACTH-independent bilateral macronodular adrenal hyperplasia (BMAH) is Abstract #100 usually associated with Cushing’s syndrome and suppressed ACTH. In CAH on the other hand, steroidogenesis is ACTH AUTONOMOUS MASSIVE MACRONODULAR mediated and levels are usually elevated >70. Our patient had ADRENALS IN THE SETTING OF CONGENITAL an ACTH in the normal range indicating that the adrenals ADRENAL HYPERPLASIA seemed to have become partially autonomous. The presence of long-term untreated CAH caused the adrenals over time to Joyce George, MD, Betul Hatipoglu, MD, Adi Mehta, MD become autonomous and escape the control of ACTH. Conclusion: A very interesting case depicting the co- Cleveland Clinic Foundation occurrence of BMAH and CAH. BMAH is one situation where one should check a 17-OHP level. Case Presentation: A 74 year old male presented to our Endocrinology clinic for workup of incidentally found Abstract #101 adrenal enlargement and nodules on CT.
    [Show full text]
  • Coincidence of Large Adrenal Cyst and Prominent Hyporeninemic Hyperaldosteronism
    Hindawi Case Reports in Endocrinology Volume 2021, Article ID 8860498, 6 pages https://doi.org/10.1155/2021/8860498 Case Report Coincidence of Large Adrenal Cyst and Prominent Hyporeninemic Hyperaldosteronism Takaaki Sakaue,1 Yosuke Okuno ,1 Kosuke Mukai ,1 Shingo Fujita,1 Junji Kozawa,1 Hitoshi Nishizawa,1 Taka-Aki Matsuoka,1 Hiromi Iwahashi,1,2 Maeda Norikazu,1,3 Yuto Yamazaki,4 Hironobu Sasano,4 Michio Otsuki ,1 and Iichiro Shimomura1 1Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan 2Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan 3Department of Metabolism and Atherosclerosis, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan 4Department of Pathology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan Correspondence should be addressed to Yosuke Okuno; [email protected] and Michio Otsuki; otsuki@ endmet.med.osaka-u.ac.jp Received 21 August 2020; Revised 28 January 2021; Accepted 11 February 2021; Published 20 February 2021 Academic Editor: Mihail A. Boyanov Copyright © 2021 Takaaki Sakaue et al. -is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A 67-year-old Japanese woman who had end-stage renal disease was referred to our hospital for kidney transplantation. Ab- dominal CTrevealed a large adrenal mass with inhomogeneity. She had a history of hospitalization for stroke and heart failure and exhibited prominent hyporeninemic hyperaldosteronism. Histological examination of the resected tumor with anti-CYP11B2 antibody indicated that she had a vascular endothelial cyst with primary aldosteronism (PA) due to multiple adrenocortical micronodules.
    [Show full text]
  • Clinical Characterization of Patients with Primary Aldosteronism Plus
    Yasuda et al. BMC Endocrine Disorders (2020) 20:9 https://doi.org/10.1186/s12902-020-0490-0 RESEARCH ARTICLE Open Access Clinical characterization of patients with primary aldosteronism plus subclinical Cushing’s syndrome Shigemitsu Yasuda1* , Yusuke Hikima1, Yusuke Kabeya2, Shinichiro Iida1, Yoichi Oikawa1, Masashi Isshiki1, Ikuo Inoue1, Akira Shimada1 and Mitsuhiko Noda1,3 Abstract Background: Primary aldosteronism (PA) plus subclinical Cushing’s syndrome (SCS), PASCS, has occasionally been reported. We aimed to clinically characterize patients with PASCS who are poorly profiled. Methods: A population-based, retrospective, single-center, observational study was conducted in 71 patients (age, 58.2 ± 11.2 years; 24 males and 47 females) who developed PA (n = 45), SCS (n = 12), or PASCS (n = 14). The main outcome measures were the proportion of patients with diabetes mellitus (DM), serum potassium concentration, and maximum tumor diameter (MTD) on the computed tomography (CT) scans. Results: The proportion of DM patients was significantly greater in the PASCS group than in the PA group (50.0% vs. 13.9%, p < 0.05), without a significant difference between the PASCS and SCS groups. Serum potassium concentration was significantly lower in the PASCS group than in the SCS group (3.2 ± 0.8 mEq/L vs. 4.0 ± 0.5 mEq/L; p < 0.01), without a significant difference between the PASCS and PA groups. Among the 3 study groups of patients who had a unilateral adrenal tumor, MTD was significantly greater in the PASCS group than in the PA group (2.7 ± 0.1 cm vs. 1.4 ± 0.1 cm; p < 0.001), without a significant difference between the PASCS and SCS groups.
    [Show full text]